-
2
-
-
0031001278
-
Iron-chelating therapy and the treatment of thalassemia
-
Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-761.
-
(1997)
Blood
, vol.89
, pp. 739-761
-
-
Olivieri, N.F.1
Brittenham, G.M.2
-
3
-
-
14544288577
-
Deferiprone therapy for transfusional iron overload
-
Victor Hoffbrand A. Deferiprone therapy for transfusional iron overload. Best Pract Res Clin Haematol. 2005;18:299-317.
-
(2005)
Best Pract Res Clin Haematol
, vol.18
, pp. 299-317
-
-
Victor Hoffbrand, A.1
-
5
-
-
29744447450
-
Combined therapy with deferoxamine and deferiprone
-
Kattamis A. Combined therapy with deferoxamine and deferiprone. Ann N Y Acad Sci. 2005;1054:175-182.
-
(2005)
Ann N Y Acad Sci
, vol.1054
, pp. 175-182
-
-
Kattamis, A.1
-
6
-
-
0034783438
-
Chelation therapy in beta-thalassemia: An optimistic update
-
Giardina PJ, Grady RW. Chelation therapy in beta-thalassemia: an optimistic update. Semin Hematol. 2001;38:360-366.
-
(2001)
Semin Hematol
, vol.38
, pp. 360-366
-
-
Giardina, P.J.1
Grady, R.W.2
-
7
-
-
27144560152
-
Combined therapy with deferiprone and desferrioxamine in thalassemia major
-
Origa R, Bina P, Agus A, et al. Combined therapy with deferiprone and desferrioxamine in thalassemia major. Haematologica. 2005;90:1309-1314.
-
(2005)
Haematologica
, vol.90
, pp. 1309-1314
-
-
Origa, R.1
Bina, P.2
Agus, A.3
-
8
-
-
0034928342
-
Exploring the "iron shuttle" hypothesis in chelation therapy: Effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture
-
Link G, Konijn AM, Breuer W, et al. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture. J Lab Clin Med. 2001;138:130-138.
-
(2001)
J Lab Clin Med
, vol.138
, pp. 130-138
-
-
Link, G.1
Konijn, A.M.2
Breuer, W.3
-
9
-
-
0347363715
-
Combined therapy with desferrioxamine and deferiprone in thalassemic patients: Effect on urinary iron excretion
-
Kattamis A, Kassou C, Berdousi H, et al. Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion. Haematologica. 2003;88:1423-1425.
-
(2003)
Haematologica
, vol.88
, pp. 1423-1425
-
-
Kattamis, A.1
Kassou, C.2
Berdousi, H.3
-
10
-
-
84908219488
-
Statistical methods for assessing agreement between two methods of clinical measurement
-
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
-
(1986)
Lancet
, vol.1
, pp. 307-310
-
-
Bland, J.M.1
Altman, D.G.2
-
11
-
-
0031784438
-
Combined therapy with deferiprone and desferrioxamine
-
Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol. 1998;103:361-364.
-
(1998)
Br J Haematol
, vol.103
, pp. 361-364
-
-
Wonke, B.1
Wright, C.2
Hoffbrand, A.V.3
-
12
-
-
0242584372
-
Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients
-
Mourad FH, Hoffbrand AV, Sheikh-Taha M, et al. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients. Br J Haematol. 2003;121:187-189.
-
(2003)
Br J Haematol
, vol.121
, pp. 187-189
-
-
Mourad, F.H.1
Hoffbrand, A.V.2
Sheikh-Taha, M.3
-
13
-
-
33646677440
-
Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
-
Daar S, Pathare AV. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol. 2006;85:315-319.
-
(2006)
Ann Hematol
, vol.85
, pp. 315-319
-
-
Daar, S.1
Pathare, A.V.2
-
14
-
-
33745531237
-
Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators
-
Kolnagou A, Kontoghiorghes GJ. Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators. Hemoglobin. 2006;30:239-249.
-
(2006)
Hemoglobin
, vol.30
, pp. 239-249
-
-
Kolnagou, A.1
Kontoghiorghes, G.J.2
-
15
-
-
33748742706
-
Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major
-
Christoforidis A, Perifanis V, Athanassiou-Metaxa M. Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006;135:271-272.
-
(2006)
Br J Haematol
, vol.135
, pp. 271-272
-
-
Christoforidis, A.1
Perifanis, V.2
Athanassiou-Metaxa, M.3
-
16
-
-
0036431540
-
Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia
-
Porter JB, Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol. 2002;15:329-368.
-
(2002)
Best Pract Res Clin Haematol
, vol.15
, pp. 329-368
-
-
Porter, J.B.1
Davis, B.A.2
-
17
-
-
0017356978
-
Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine
-
Hussain MA, Green N, Flynn DM, et al. Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet. 1977;1:977-979.
-
(1977)
Lancet
, vol.1
, pp. 977-979
-
-
Hussain, M.A.1
Green, N.2
Flynn, D.M.3
-
18
-
-
0024521376
-
Desferrioxamine-induced iron excretion in humans
-
Pippard MJ. Desferrioxamine-induced iron excretion in humans. Baillieres Clin Haematol. 1989;2:323-343.
-
(1989)
Baillieres Clin Haematol
, vol.2
, pp. 323-343
-
-
Pippard, M.J.1
|